BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,446 | -65.8% | 16,777 | -10.0% | 0.00% | – |
| Q2 2023 | $124,196 | -52.6% | 18,648 | +32.7% | 0.00% | – |
| Q1 2023 | $262,210 | -23.4% | 14,052 | -11.8% | 0.00% | – |
| Q4 2022 | $342,155 | +141.0% | 15,929 | +32.8% | 0.00% | – |
| Q3 2022 | $142,000 | -12.9% | 11,991 | -2.6% | 0.00% | – |
| Q2 2022 | $163,000 | -28.8% | 12,315 | +12.6% | 0.00% | – |
| Q1 2022 | $229,000 | -7.3% | 10,936 | +34.6% | 0.00% | – |
| Q3 2021 | $247,000 | +17.1% | 8,127 | +12.1% | 0.00% | – |
| Q2 2021 | $211,000 | -69.9% | 7,253 | -55.1% | 0.00% | -100.0% |
| Q3 2020 | $700,000 | – | 16,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |